Rangeley Capital, LLC
13F Reported Value
ⓘ$102.9M
incl. option notional
Equity Holdings
ⓘ$92.6M
Option Notional
ⓘ$10.3M
$5.7M puts / $4.6M calls
Holdings
137
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Rangeley Capital, LLC disclosed 137 positions worth $102.9M in its Form 13F-HR for Q1 2026 — $92.6M in common stock plus $10.3M of put/call option positions (reported at underlying notional value, not premium at risk), led by $DRVN (Driven Brands Holdings Inc.) at 8.5% of the equity portfolio, followed by $LQDA. During the quarter the fund opened 44 new positions and exited 27 — including a new stake in $DRVN and a full exit from $GDEN. The portfolio is most concentrated in Healthcare (27.3% of disclosed assets). All figures are sourced directly from Rangeley Capital, LLC’s Form 13F-HR filing with the SEC under CIK 1517796.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 52.8#1,326
Quality
$7.9M625,500 sh - 37.4#2,056
Quality
$5.7M150,000 sh PROTHENA CORP PLC
—Quality
$4.4M449,460 sh- 13.3
Quality
$3.3M153,517 sh - 37.4
Quality
$2.8M75,000 sh - 72.8
Quality
$2.8M234,000 sh - 33.9
Quality
$2.7M60,000 sh - 13.9
Quality
$2.4M223,990 sh - —
Quality
$2.3M500,000 sh - 29.5
Quality
$2.1M18,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 52.8#1,326 | $7.9M | 625,500 | |
| 37.4#2,056 | $5.7M | 150,000 | |
| PROTHENA CORP PLC | — | $4.4M | 449,460 |
| 13.3 | $3.3M | 153,517 | |
| 37.4 | $2.8M | 75,000 | |
| 72.8 | $2.8M | 234,000 | |
| 33.9 | $2.7M | 60,000 | |
| 13.9 | $2.4M | 223,990 | |
| — | $2.3M | 500,000 | |
| 29.5 | $2.1M | 18,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Rangeley Capital, LLC's 137 positions.
Showing top 10 of 137 holdings.
Sector Allocation
Healthcare
$25.3M
Consumer Discretionary
$17.1M
Financials
$11.6M
Real Estate
$9.2M
Communication Services
$7.8M
Technology
$7.2M
Energy
$5.0M
Other
$4.4M
Full Holdings — Rangeley Capital, LLC (Q1 2026)
All 137 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Driven Brands Holdings Inc. | $7.9M | 8.5% | NEW | 52.8 | |
| 2 | Liquidia Corp | $5.7M | — | NEW | 37.4 | |
| 3 | — | PROTHENA CORP PLC | $4.4M | 4.7% | -14% | — |
| 4 | Seaport Entertainment Group Inc. | $3.3M | 3.6% | +0% | 13.3 | |
| 5 | Liquidia Corp | $2.8M | — | NEW | 37.4 | |
| 6 | Grindr Inc. | $2.8M | 3.0% | +10% | 72.8 | |
| 7 | Delek US Holdings, Inc. | $2.7M | 2.9% | -41% | 33.9 | |
| 8 | ARVINAS, INC. | $2.4M | 2.6% | -43% | 13.9 | |
| 9 | Arbutus Biopharma Corp | $2.3M | 2.4% | -40% | — | |
| 10 | EchoStar CORP | $2.1M | 2.3% | -25% | 29.5 | |
| 11 | LEGGETT & PLATT INC | $2.1M | 2.3% | +57% | 55.9 | |
| 12 | Star Holdings | $2.1M | 2.2% | +46% | 25.9 | |
| 13 | FULL HOUSE RESORTS INC | $2.1M | 2.2% | +2% | 33.9 | |
| 14 | TripAdvisor, Inc. | $2.0M | 2.2% | NEW | 51.5 | |
| 15 | Orion Properties Inc. | $2.0M | 2.1% | NEW | 20.5 | |
| 16 | ICON PLC | $2.0M | 2.1% | NEW | — | |
| 17 | Calumet, Inc. /DE | $1.9M | 2.0% | -80% | 34.7 | |
| 18 | GREEN DOT CORP | $1.8M | 2.0% | NEW | 53.1 | |
| 19 | Kezar Life Sciences, Inc. | $1.8M | 1.9% | +183% | — | |
| 20 | Janux Therapeutics, Inc. | $1.7M | 1.8% | +382% | 24.8 | |
| 21 | Theravance Biopharma, Inc. | $1.7M | 1.8% | NEW | 68.9 | |
| 22 | Mister Car Wash, Inc. | $1.5M | 1.7% | NEW | 58.7 | |
| 23 | Brighthouse Financial, Inc. | $1.5M | 1.6% | +0% | 54.9 | |
| 24 | Warner Bros. Discovery, Inc. | $1.5M | — | -9% | 42.1 | |
| 25 | ZIM Integrated Shipping Services Ltd. | $1.4M | 1.6% | +34% | — | |
| 26 | FORWARD AIR CORP | $1.4M | 1.5% | +12% | 52.4 | |
| 27 | Warner Bros. Discovery, Inc. | $1.4M | 1.5% | -76% | 42.1 | |
| 28 | Net Lease Office Properties | $1.3M | 1.4% | +68% | 26.7 | |
| 29 | Elme Communities | $1.3M | 1.4% | NEW | 34.6 | |
| 30 | Revolution Medicines, Inc. | $1.2M | 1.3% | NEW | — | |
| 31 | BICYCLE THERAPEUTICS PLC | $1.1M | 1.2% | +76% | — | |
| 32 | SWK Holdings Corp | $1.1M | 1.2% | +0% | — | |
| 33 | Kennedy-Wilson Holdings, Inc. | $1.0M | 1.1% | -72% | 29.7 | |
| 34 | HOLOGIC INC | $982,670 | 1.1% | NEW | 62.3 | |
| 35 | Hilton Grand Vacations Inc. | $978,000 | 1.1% | +67% | 48.1 | |
| 36 | Septerna, Inc. | $956,394 | 1.0% | -40% | 44.6 | |
| 37 | WEN Acquisition Corp | $865,300 | 0.9% | +36% | — | |
| 38 | MONRO, INC. | $839,598 | 0.9% | NEW | 38.9 | |
| 39 | Kura Oncology, Inc. | $822,919 | 0.9% | -2% | 9.1 | |
| 40 | SELECT MEDICAL HOLDINGS CORP | $814,500 | 0.9% | -38% | 60.1 | |
| 41 | Clearwater Analytics Holdings, Inc. | $662,200 | 0.7% | -65% | 50.2 | |
| 42 | Roman DBDR Acquisition Corp. II | $628,200 | 0.7% | +39% | — | |
| 43 | Keros Therapeutics, Inc. | $600,576 | 0.7% | -44% | 57.2 | |
| 44 | ENVIRI Corp | $549,360 | 0.6% | +162% | 35.6 | |
| 45 | D-MARKET Electronic Services & Trading | $524,000 | 0.6% | +0% | — | |
| 46 | Braemar Hotels & Resorts Inc. | $523,920 | 0.6% | +200% | 52.1 | |
| 47 | General Purpose Acquisition Corp. | $500,500 | 0.5% | +0% | — | |
| 48 | Abivax S.A. | $445,400 | 0.5% | +0% | — | |
| 49 | Monte Rosa Therapeutics, Inc. | $444,413 | 0.5% | -60% | 18.1 | |
| 50 | Distribution Solutions Group, Inc. | $442,328 | 0.5% | NEW | 53.1 | |
| 51 | Oaktree Acquisition Corp. III Life Sciences | $423,571 | 0.5% | +53% | — | |
| 52 | Corbus Pharmaceuticals Holdings, Inc. | $421,048 | 0.5% | NEW | — | |
| 53 | Globa Terra Acquisition Corp | $420,360 | 0.5% | +0% | — | |
| 54 | New America Acquisition I Corp. | $414,000 | 0.5% | +0% | — | |
| 55 | IMMERSION CORP | $409,500 | 0.4% | NEW | 49.9 | |
| 56 | OnKure Therapeutics, Inc. | $393,300 | 0.4% | -34% | — | |
| 57 | STRATUS PROPERTIES INC | $382,904 | 0.4% | NEW | 17.3 | |
| 58 | Yext, Inc. | $381,420 | 0.4% | -83% | 55 | |
| 59 | Adicet Bio, Inc. | $381,360 | 0.4% | +124% | — | |
| 60 | LISATA THERAPEUTICS, INC. | $375,750 | 0.4% | NEW | — | |
| 61 | LENSAR, Inc. | $375,480 | 0.4% | +7% | 50.7 | |
| 62 | Inhibikase Therapeutics, Inc. | $369,600 | 0.4% | NEW | — | |
| 63 | APARTMENT INVESTMENT & MANAGEMENT CO | $366,300 | 0.4% | NEW | 56.3 | |
| 64 | Centessa Pharmaceuticals plc | $357,480 | 0.4% | NEW | — | |
| 65 | Smart Share Global Ltd | $346,910 | 0.4% | -36% | — | |
| 66 | FORWARD AIR CORP | $335,871 | — | -10% | 52.4 | |
| 67 | Drugs Made In America Acquisition II Corp. | $326,812 | 0.3% | +71% | — | |
| 68 | Fifth Era Acquisition Corp I | $319,197 | 0.3% | -7% | — | |
| 69 | E.W. SCRIPPS Co | $318,023 | 0.3% | NEW | 37.3 | |
| 70 | Sable Offshore Corp. | $313,880 | 0.3% | +0% | — | |
| 71 | Trilogy Metals Inc. | $312,330 | 0.3% | +0% | — | |
| 72 | Seer, Inc. | $309,627 | 0.3% | +822% | 11.8 | |
| 73 | ENTRAVISION COMMUNICATIONS CORP | $297,000 | 0.3% | +11% | 28.2 | |
| 74 | 4D Molecular Therapeutics, Inc. | $292,939 | 0.3% | -19% | 23.2 | |
| 75 | PLIANT THERAPEUTICS, INC. | $283,500 | 0.3% | +0% | — | |
| 76 | Grocery Outlet Holding Corp. | $282,000 | 0.3% | NEW | 44.1 | |
| 77 | OTG Acquisition Corp. I | $281,805 | 0.3% | +85% | — | |
| 78 | Priority Technology Holdings, Inc. | $278,480 | 0.3% | -3% | 59.2 | |
| 79 | D. Boral ARC Acquisition I Corp. | $274,887 | 0.3% | +114% | — | |
| 80 | Rallybio Corp | $270,266 | 0.3% | -25% | — | |
| 81 | ABEONA THERAPEUTICS INC. | $268,800 | 0.3% | +4% | 44.3 | |
| 82 | CSLM Digital Asset Acquisition Corp III, Ltd | $265,356 | 0.3% | +88% | — | |
| 83 | USA TODAY Co., Inc. | $262,965 | 0.3% | -21% | 48.4 | |
| 84 | Atea Pharmaceuticals, Inc. | $250,170 | 0.3% | -42% | — | |
| 85 | PETMED EXPRESS INC | $248,994 | 0.3% | +46% | 15.3 | |
| 86 | CADIZ INC | $245,500 | 0.3% | -80% | 28.9 | |
| 87 | Core Scientific, Inc./tx | $237,728 | 0.3% | -72% | 14 | |
| 88 | Pioneer Acquisition I Corp | $228,094 | 0.3% | +0% | — | |
| 89 | FutureCrest Acquisition Corp. | $221,903 | 0.2% | NEW | — | |
| 90 | WW INTERNATIONAL, INC. | $219,840 | 0.2% | +33% | 26.4 | |
| 91 | EXELIXIS, INC. | $214,450 | 0.2% | +0% | 79.4 | |
| 92 | uniQure N.V. | $212,550 | 0.2% | +53% | — | |
| 93 | Republic Digital Acquisition Co | $206,523 | 0.2% | +0% | — | |
| 94 | ELECTRONIC ARTS INC. | $203,870 | 0.2% | NEW | 71.1 | |
| 95 | Highview Merger Corp. | $203,400 | 0.2% | +0% | — | |
| 96 | Emmis Acquisition Corp. | $181,975 | 0.2% | +0% | — | |
| 97 | FMC CORP | $172,200 | 0.2% | NEW | 28.6 | |
| 98 | ImageneBio, Inc. | $162,950 | 0.2% | +79% | 3.9 | |
| 99 | FACT II Acquisition Corp. | $162,855 | 0.2% | NEW | — | |
| 100 | Berto Acquisition Corp. | $158,875 | 0.2% | -95% | — | |
| 101 | International Money Express, Inc. | $158,000 | 0.2% | +0% | 36.9 | |
| 102 | Mountain Lake Acquisition Corp. | $157,952 | 0.2% | +0% | — | |
| 103 | PagerDuty, Inc. | $155,250 | 0.2% | NEW | 66.6 | |
| 104 | DigitalBridge Group, Inc. | $154,200 | 0.2% | -28% | 52.9 | |
| 105 | Nkarta, Inc. | $143,480 | 0.1% | +112% | — | |
| 106 | Sotera Health Co | $143,400 | 0.1% | NEW | 59.7 | |
| 107 | Renatus Tactical Acquisition Corp I | $128,582 | 0.1% | NEW | — | |
| 108 | Dingdong (Cayman) Ltd | $128,500 | 0.1% | NEW | — | |
| 109 | HCM III ACQUISITION CORP. | $126,302 | 0.1% | -11% | — | |
| 110 | Spark I Acquisition Corp | $122,295 | 0.1% | +0% | — | |
| 111 | Rezolute, Inc. | $122,000 | 0.1% | -49% | — | |
| 112 | PepGen Inc. | $120,530 | 0.1% | +88% | — | |
| 113 | TWO HARBORS INVESTMENT CORP. | $114,200 | 0.1% | NEW | — | |
| 114 | CEMENTOS PACASMAYO SAA | $112,210 | 0.1% | -6% | — | |
| 115 | Mereo BioPharma Group plc | $108,636 | 0.1% | -10% | — | |
| 116 | Real Asset Acquisition Corp. | $105,000 | 0.1% | +0% | — | |
| 117 | Sizzle Acquisition Corp. II | $102,800 | 0.1% | NEW | — | |
| 118 | Cohen Circle Acquisition Corp. II | $102,300 | 0.1% | -52% | — | |
| 119 | Kyivstar Group Ltd. | $101,200 | 0.1% | NEW | — | |
| 120 | Barinthus Biotherapeutics plc. | $90,736 | 0.1% | +89% | — | |
| 121 | PRESIDIO PRODUCTION Co | $85,124 | 0.1% | NEW | — | |
| 122 | PMV Pharmaceuticals, Inc. | $82,889 | 0.1% | +47% | — | |
| 123 | Acumen Pharmaceuticals, Inc. | $82,600 | 0.1% | NEW | — | |
| 124 | DOMO, INC. | $79,560 | 0.1% | NEW | 24.1 | |
| 125 | SITE Centers Corp. | $75,600 | 0.1% | +0% | 52.6 | |
| 126 | VYNE Therapeutics Inc. | $70,543 | 0.1% | +18% | — | |
| 127 | TaskUs, Inc. | $67,100 | 0.1% | +0% | 68.7 | |
| 128 | MACROGENICS INC | $62,135 | 0.1% | -29% | 31.7 | |
| 129 | Invivyd, Inc. | $58,500 | 0.1% | NEW | 25.7 | |
| 130 | Burford Capital Ltd | $52,292 | 0.1% | -80% | — | |
| 131 | Great Elm Capital Corp. | $50,100 | 0.1% | NEW | — | |
| 132 | STANDARD BIOTOOLS INC. | $45,965 | 0.1% | NEW | 38.8 | |
| 133 | Clear Channel Outdoor Holdings, Inc. | $44,082 | 0.1% | NEW | 47.1 | |
| 134 | — | ALT5 SIGMA CORP | $28,860 | 0.0% | -10% | — |
| 135 | Alight, Inc. / Delaware | $28,823 | 0.0% | NEW | 34.4 | |
| 136 | KIORA PHARMACEUTICALS INC | $19,300 | 0.0% | NEW | — | |
| 137 | Xerox Holdings Corp | $9,050 | 0.0% | NEW | 38.6 |
New Positions (44)
Exited Positions (27)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Rangeley Capital, LLC including:
Track Rangeley Capital, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Rangeley Capital, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Rangeley Capital, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Rangeley Capital, LLC (SEC CIK: 1517796), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Rangeley Capital, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.